Effectiveness of intramuscular aripiprazole injection in patients with catatonia

Report on three cases

V. Voros, A. Kovacs, R. Herold, P. Osváth, M. Simón, S. Fekete, T. Tényi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In the recent literature, orally administered aripiprazole, a second generation antipsychotic, was demonstrated to be effective in the resolution of catatonia. Our present paper is the first report of three cases of catatonia where intramuscularly administered high doses of aripiprazole were found to be effective in resolving severe catatonic states, independent of the features, or of the origin of catatonia, presenting either in schizophrenia or in major depression. On the basis of the unique mechanism of action of the drug and based on our clinical experience, we recommend the use of high doses of intramuscular aripiprazole as an alternative treatment for catatonia, when benzodiazepines or electroconvulsive therapy are not effective or not proposed.

Original languageEnglish
Pages (from-to)286-287
Number of pages2
JournalPharmacopsychiatry
Volume42
Issue number6
DOIs
Publication statusPublished - Nov 2009

Fingerprint

Catatonia
Intramuscular Injections
Electroconvulsive Therapy
Benzodiazepines
Antipsychotic Agents
Schizophrenia
Depression
Aripiprazole
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health

Cite this

Effectiveness of intramuscular aripiprazole injection in patients with catatonia : Report on three cases. / Voros, V.; Kovacs, A.; Herold, R.; Osváth, P.; Simón, M.; Fekete, S.; Tényi, T.

In: Pharmacopsychiatry, Vol. 42, No. 6, 11.2009, p. 286-287.

Research output: Contribution to journalArticle

@article{65c7a2082ccc449a9cec079fa9f197c8,
title = "Effectiveness of intramuscular aripiprazole injection in patients with catatonia: Report on three cases",
abstract = "In the recent literature, orally administered aripiprazole, a second generation antipsychotic, was demonstrated to be effective in the resolution of catatonia. Our present paper is the first report of three cases of catatonia where intramuscularly administered high doses of aripiprazole were found to be effective in resolving severe catatonic states, independent of the features, or of the origin of catatonia, presenting either in schizophrenia or in major depression. On the basis of the unique mechanism of action of the drug and based on our clinical experience, we recommend the use of high doses of intramuscular aripiprazole as an alternative treatment for catatonia, when benzodiazepines or electroconvulsive therapy are not effective or not proposed.",
author = "V. Voros and A. Kovacs and R. Herold and P. Osv{\'a}th and M. Sim{\'o}n and S. Fekete and T. T{\'e}nyi",
year = "2009",
month = "11",
doi = "10.1055/s-0029-1224185",
language = "English",
volume = "42",
pages = "286--287",
journal = "Pharmacopsychiatry",
issn = "0176-3679",
publisher = "Georg Thieme Verlag",
number = "6",

}

TY - JOUR

T1 - Effectiveness of intramuscular aripiprazole injection in patients with catatonia

T2 - Report on three cases

AU - Voros, V.

AU - Kovacs, A.

AU - Herold, R.

AU - Osváth, P.

AU - Simón, M.

AU - Fekete, S.

AU - Tényi, T.

PY - 2009/11

Y1 - 2009/11

N2 - In the recent literature, orally administered aripiprazole, a second generation antipsychotic, was demonstrated to be effective in the resolution of catatonia. Our present paper is the first report of three cases of catatonia where intramuscularly administered high doses of aripiprazole were found to be effective in resolving severe catatonic states, independent of the features, or of the origin of catatonia, presenting either in schizophrenia or in major depression. On the basis of the unique mechanism of action of the drug and based on our clinical experience, we recommend the use of high doses of intramuscular aripiprazole as an alternative treatment for catatonia, when benzodiazepines or electroconvulsive therapy are not effective or not proposed.

AB - In the recent literature, orally administered aripiprazole, a second generation antipsychotic, was demonstrated to be effective in the resolution of catatonia. Our present paper is the first report of three cases of catatonia where intramuscularly administered high doses of aripiprazole were found to be effective in resolving severe catatonic states, independent of the features, or of the origin of catatonia, presenting either in schizophrenia or in major depression. On the basis of the unique mechanism of action of the drug and based on our clinical experience, we recommend the use of high doses of intramuscular aripiprazole as an alternative treatment for catatonia, when benzodiazepines or electroconvulsive therapy are not effective or not proposed.

UR - http://www.scopus.com/inward/record.url?scp=70450240820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450240820&partnerID=8YFLogxK

U2 - 10.1055/s-0029-1224185

DO - 10.1055/s-0029-1224185

M3 - Article

VL - 42

SP - 286

EP - 287

JO - Pharmacopsychiatry

JF - Pharmacopsychiatry

SN - 0176-3679

IS - 6

ER -